New! Make Your CRM Smarter with Best-In-Class Intent Data

Learn More!
Genomind

Genomind

Genomind is a pharmacogenetic testing laboratory specializing in personalized medicine in the field of psychiatry, comprised of innovative researchers and expert leaders in psychiatry and neurology. Genomind is committed to discovery of the underlying causes of neuropsychiatric disorders and supports the development of personalized medicine that improves patients' lives. Genomind was founded by Ronald I. Dozoretz, MD, a psychiatrist who has devoted his career to improving mental health. Jay Lombard, DO, a neurologist and co-founder of Genomind, is a critically acclaimed author and nationally recognized thought leader in neuropsychiatry practice and research.

Last updated on

About Genomind

Founded

2009

Estimated Revenue

$10M-$50M

Employees

51-250

Funding / Mkt. Cap

$92M

Category

Industry

Biotechnology

Location

City

King of Prussia

State

Pennsylvania

Country

United States